TPG Group Holdings (SBS) Advisors’s Aerie Pharmaceuticals AERI Stock Holding History

TPG Group Holdings (SBS) Advisors’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,237,466	Closed	-$46.7M	–	66
2016 Q3	$46.7M	Hold	1,237,466	–	–	0.47%	26
2016 Q2	$21.8M	Hold	1,237,466	–	–	0.24%	37
2016 Q1	$15M	Hold	1,237,466	–	–	0.15%	40
2015 Q4	$30.1M	Hold	1,237,466	–	–	0.22%	32
2015 Q3	$22M	Hold	1,237,466	–	–	0.11%	34
2015 Q2	$21.8M	Sell	1,237,466 -600,000	-33%	-$11M	0.1%	31
2015 Q1	$57.6M	Sell	1,837,466 -250,000	-12%	-$7.25M	0.29%	14
2014 Q4	$60.9M	Sell	2,087,466 -1,300,000	-38%	-$33M	0.37%	14
2014 Q3	$70.1M	Sell	3,387,466 -1,000,000	-23%	-$19.7M	0.47%	13
2014 Q2	$109M	Hold	4,387,466	–	–	0.68%	13
2014 Q1	$93M	Hold	4,387,466	–	–	0.98%	12
2013 Q4	$78.8M	Buy	+4,387,466	New	+$57.2M	0.95%	12

Other funds holding AERI

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TPG Group Holdings (SBS) Advisors's AERI Position: Q4 2016 in Review

TPG Group Holdings (SBS) Advisors sold out of Aerie Pharmaceuticals (AERI) in Q4 2016, closing a stake of 1,237,466 shares — an estimated $46.7M sold.

TPG Group Holdings (SBS) Advisors first reported a position in AERI in Q4 2013 and held it in 12 quarters. The position peaked at $109M in Q2 2014. 151 funds tracked by Wall St. Rank hold AERI as of Q4 2016.

TPG Group Holdings (SBS) Advisors reported no remaining Aerie Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
TPG Group Holdings (SBS) Advisors sold 1,237,466 Aerie Pharmaceuticals shares in Q4 2016, an estimated $46.7M.
TPG Group Holdings (SBS) Advisors first reported a position in Aerie Pharmaceuticals in Q4 2013 and held it in 12 quarters.
TPG Group Holdings (SBS) Advisors's Aerie Pharmaceuticals position peaked at $109M in Q2 2014.
151 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2016.

Based on TPG Group Holdings (SBS) Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.